Next Quarterly Earnings
Wednesday, August 12, 2026
CW 33
Pre-Market
In 38 days
Novavax is a global biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative vaccines. Utilizing proprietary protein nanoparticle technology, Novavax creates crucial immunizations against severe infectious diseases, including influenza and COVID-19, thereby contributing to global health.